Financial insights of CDTX

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenues	0	0	-	-
Acquired in-process research and development	45,000	0	-	-
Research and development	35,529	24,817	24,600	12,429
General and administrative	8,099	6,502	6,179	4,965
Reversal due to settlement of indirect tax liabilities	0	-3,935	-5,510	-
Total operating expenses	88,628	27,384	25,269	17,394
Loss from operations	-88,628	-27,384	-25,269	-17,394
Other expense, net	0	0	110	-
Interest income, net	5,395	1,666	1,899	1,859
Total other income, net	5,395	1,666	1,789	1,859
Net loss from continuing operations before income tax expense	-	-	-	-15,535
Net loss from continuing operations	-83,233	-25,718	-23,480	-15,535
(loss) income from discontinued operations (including loss on disposal of discontinued operations of zero and 1,799 during the three and nine months ended september 30, 2024, respectively), net of income taxes	0	0	-	-450
Net loss	-83,233	-25,718	-23,480	-15,985
Unrealized loss on available-for-sale investments	-107	-	-	-
Comprehensive loss	-83,340	-	-	-

Basic net loss per common share (in dollars per share)	-3.1	-1.65	-1.66	-2.45
Diluted net loss per common share (in dollars per share)	-3.1	-1.65	-1.66	-2.45
Shares used to compute basic net earnings (loss) per common share (in shares)	26,882,366	15,547,403	14,177,743	6,530,111
Shares used to compute diluted net earnings (loss) per common share (in shares)	26,882,366	15,547,403	14,177,743	6,530,111